CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: AFQ056 for Language Learning in Children With FXS [Phase 2]
Summary
Phase 2 trial update for AFQ056 in language learning in children with Fragile X Syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elizabeth Berry-Kravis | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2023-10-10